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Purpose: Glaucoma prevalence can vary geographically and ethnically, which suggests that a genetic element could play
a significant role. Studies investigating the role of various mitochondrial haplogroups in the pathogenesis of glaucoma
are scarce.
Methods: We compared the prevalence of different mitochondrial haplogroups in 107 glaucoma patients (49 primary
open-angle glaucoma, POAG; 29 primary angle-closure glaucoma, PACG; and 29 pseudoexfoliation glaucoma, PEG)
and 552 maternally unrelated normal controls. All patients and controls were Saudi Arabs.
Results: There was no statistically significant difference between patients and controls for all mitochondrial haplogroups
tested except for PACG patients with mitochondrial haplogroup preHV1 (odds ratio=4.9; 95% CI 2.3 – 10.5; p=0.00002).
Conclusions: Patients with preHV1 mitochondrial haplogroups are at higher risk of developing PACG. However, our
study group is relatively small and further studies with more patients in other populations are needed to confirm this
interesting finding.
During evolution, several mutations have accumulated in
mitochondrial DNA (mtDNA), representing specific single
nucleotide  polymorphisms  (SNPs),  allowing  human
populations  to  be  categorized  into  various  mtDNA
haplogroups. In certain populations, these haplogroups were
found  to  confer  resistance  against  type  2  diabetes  [1],
influence energy dependent processes such as sperm motility
and  the  risk  of  developing  late  onset  neurodegenerative
diseases [2], and contribute to the development of various
types of cancer [3-7], Parkinson disease [8], and multiple
sclerosis [9].
Glaucoma  prevalence  can  vary  by  geography  and  by
ethnicity [10-13], suggesting that a genetic element could play
a significant role. In the western world, in predominantly
Caucasian groups for instance, primary open-angle glaucoma
(POAG) is the most commonly encountered adult onset type
of  glaucoma  [14]  while  primary  angle-closure  glaucoma
(PACG) has been reported much more frequently in Asiatic
populations [15-17]. Pseudoexfoliation glaucoma (PEG) has
also demonstrated wide prevalence variation around the world
[13].
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Studies investigating the role of various mitochondrial
haplogroups  in  the  pathogenesis  of  glaucoma  are  scarce.
Searching the literature, we came across only one study, which
studied the role of mitochondrial haplogroups in POAG. Their
haplogroup analysis was based on the phylogenetic network
for  European  mtDNA  [18],  and  the  results  of  this  study
concluded that mitochondrial haplogroups H, T, J, U, K, W,
I, V, X, and M do not appear to contribute to the pathogenesis
of POAG [19]. On the other hand, there is quite a fair number
of studies investigating the role of mitochondrial haplogroups
in  the  pathogenesis  of  Leber  hereditary  optic  neuropathy
(LHON). LHON is another optic nerve disease which shares
some similarities with certain types of glaucoma. LHON is
mainly caused by one of three mitochondrial DNA mutations
(11778 G>A, 14484 T>C, and 3460 G>A), which are known
as the primary LHON mutations. There is a well established
strong association between the mtDNA genetics background
and both the 11778 G>A and the 14484 T>C LHON mutations
but not the 3460 G>A. Meta-analysis of the available data has
shown that individuals with the 14484 T>C mutation are 27
times more likely to belong to western Eurasian haplogroup J
than control subjects and that individuals with the 11778 G>A
mutation are three times more likely to belong to haplogroup
J than control subjects. This was observed in western Eurasian
populations [20]. The reason for this association is not clear,
but one likely theory is that functional variants in complex I
mitochondrial  gene  interacting  synergistically  with  the
primary LHON mutation are leading to further compromise
of complex I function [21]. Here, we investigated the possible
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518association  of  mitochondrial  haplogroups  with  the
pathogenesis of the three most common types of glaucoma
(POAG,  PACG,  and  PEG)  prevalent  in  the  Saudi  Arab
population.
METHODS
Patient enrollment: A total of 107 glaucoma patients (49
POAG, 29 PACG, and 29 PEG) were included in this study.
The inclusion and exclusion criteria for each type of glaucoma
were  detailed  elsewhere  [22-24].  All  patients  were  Saudi
Arabs. Patients were selected from the Glaucoma Clinic at
King  Khaled  Eye  Specialist  Hospital  (KKESH)  after
examination by a glaucoma specialist (J.M.) and informed
consent  approved  by  the  KKESH-IRB.  Records  were
reviewed,  and  full  ophthalmologic  examinations  were
performed.  Patients  had  either  Goldmann  manual  kinetic
Figure  1.  A  schematic  representation  of  diagnostic  RFLPs  (or
variable positions sequenced) used to assort mtDNA haplotypes.
Phylogenetic relationships of all the haplogroups detected in the
glaucoma  cohort  studied  are  graphically  represented.  Diagnostic
positions, detected by RFLP or sequencing, are depicted on the
branches relating haplogroups. Positive signs (+) indicate restriction-
site gains and negative signs (-) indicate restriction-site losses.
perimetry  (Haag  Streit  International,  Koeniz-Bern,
Switzerland) or Humphrey automated white on white stimulus
static  perimetry  (Humphrey  Field  Analyzer  II,  Humphrey
Systems,  Dublin,  CA)  or  both.  Optical  Coherence
Tomography  was  performed  with  the  OCT3  Unit  by
Humphrey Systems (San Leandro, CA) on some patients.
Fundus photos were obtained using a Zeiss FF 450 system and
conventional film. This research followed the tenets of the
Declaration of Helsinki. Family members were not evaluated
clinically or genetically.
Control enrollment: Control subjects were blood donors at the
King Faisal Specialist Hospital and Research Centre who
represented the spectrum of Saudi Arabs. Buccal swabs or
peripheral blood were obtained from 552 maternally unrelated
Saudi  Arabs,  all  whose  known  ancestors  were  of  Saudi
Arabian origin. All control subjects reported no symptomatic,
metabolic,  genetic,  or  ocular  disorders  on  an  extensive
questionnaire about family history, past medical problems,
and current health.
RFLP  (sequencing)  analyses  of  haplogroup  diagnostic
positions:  To  detect  coding-region  diagnostic  haplogroup
polymorphisms, a fragment spanning the diagnostic position
was amplified using any of the 32 overlapping pairs of primers
that cover the whole mtDNA genome, and the PCR conditions
previously  published  [25].  However,  a  polymorphism  at
nucleotide  position  12,308  was  amplified  using  a  reverse
mismatch  primer  as  described  by  Torroni  et  al.  [26].
Amplified  fragments  were  digested  with  the  appropriate
restriction  endonuclease  according  to  the  supplier’s
recommendations.  Alternatively,  the  amplified  fragments
were analyzed by sequencing. For Eurasian haplogroups (H,
HV, preHV, J, T, R, U, K, I, N, X and M) diagnostic positions
were  recompiled  from  Richards  et  al.  [27].  For  African
haplogroups, L0, L1, and L3 from Chen et al. [28] and for L2,
L4,  and  L5  from  Kivisil  et  al.  [29].  Finally,  diagnostic
positions for (preHV)1 were taken from Abu-Amero et al.
[30] and for M1 from Gonzalez et al. [31].. Figure 1 shows a
schematic representation of diagnostic RFLPs (or variable
positions sequenced) used to assort mtDNA haplotypes.
Data  analysis:  The  frequency  of  each  haplogroup  among
cases and controls were compared with the Χ2 test (Fisher’s
exact  test  where  appropriate),  and  the  risk  of  having  the
disease if you have a certain haplogroup as compared to not
having that specific haplogroup was estimated by computing
odds ratio and its confidence interval. A p-value less than 0.05
was considered significant. Bonferroni correction was used to
adjust the significance level of a statistical test to protect
against Type I errors when multiple comparisons were being
made.  Since  we  have  19  mitochondrial  haplogroups,  the
Bonferroni correction should be 0.05/19=0.0026. Therefore,
a p-value less than 0.0026 was considered significant. In the
case of comparing the haplogroup distribution among each of
the three different glaucoma groups with the controls, the
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519threshold was further reduced to 0.00087. All analyses were
performed  using  SPSS  v.13  statistical  analysis  software
(SPSS Inc., Chicago, IL).
RESULTS
Our cohort consisted of 107 glaucoma patients (49 POAG, 29
PACG, and 29 PEG) and 552 ethnically matched healthy
controls.  Table  1  shows  the  mitochondrial  haplogroup
distribution among the glaucoma patients as one group and
the  controls  as  another  group.  There  was  no  statistically
significant difference between patients and controls for all
mitochondrial  haplogroups  tested.  We  then  compared  the
mitochondrial  haplogroup  distribution  for  each  type  of
glaucoma separately with the controls (Table 2). There was
no statistically significant difference between patients and
controls  for  all  haplogroups  tested  except  among  PACG
patients with haplogroup preHV1 (odds ratio=4.9; 95% CI 2.3
– 10.5; p=0.00002).
DISCUSSION
Glaucoma is the most common optic neuropathic process
affecting  humans  and  the  second  most  common  cause  of
blindness  worldwide  [32].  Previous  studies  have
demonstrated  that  glaucoma  affects  certain  ethnic  groups
disproportionately  (see  Introduction).  The  prevalence  of
different  types  of  glaucoma  in  Saudi  Arabia  is  largely
unknown.  We  found  one  eye  population  survey  where
glaucoma specialists were involved in the screening of 565
individuals older than 60. This study found that the prevalence
of PACG was as frequent as POAG and approaching that of
one reported in some Asian populations [33].
By studying 107 glaucoma patients of Saudi descent, we
demonstrated that certain mtDNA haplogroups influence the
development of certain types of glaucoma. We found that
individuals with preHV1 haplogroup were at higher risk of
developing PACG (p<0.00002). Although this association is
statistically significant, it has to be stated that the PACG group
analyzed here were small (n=29) and preHV1 is the second
most common mitochondrial haplogroup among the Saudi
population  (17.9%)  [34],  which  may  raise  some  concern
regarding this finding. Also, as the genetic diversity in Saudi
Arabia is smaller than in other Middle East areas [30,34], this
association  could  be  even  less  significant.  Additional
association  studies  with  more  patients  may  be  needed  to
eliminate casual susceptibility to PACG among individuals
with preHV1 haplogroup.
We  demonstrated  an  association  between  a  specific
mitochondrial haplogroup and a certain type of glaucoma in
the  Saudi  Arab  population.  However,  our  study  group  is
relatively small and from a relatively homogenous population.
Thus,  further  studies  with  more  patients  and  in  various
populations are needed to confirm our finding. We also cannot
ignore the fact that genetics or environmental factors other
TABLE 1. HAPLOGROUP DISTRIBUTION IN GLAUCOMA PATIENTS AND CONTROLS.
Mitochondrial
haplogroup
Controls
(n=552)
Glaucoma patients
(n=107)
Odds ratio 95% C.I. p-Value
H 47 (8.5%) 7 (6.5%) 0.75 0.30–1.79 0.62
I 5 (0.9%) 1 (0.9%) 1.03 0.17–6.20 1
J 116 (21%) 22 (20.6%) 0.97 0.56–1.67 0.98
K 22 (4%) 4 (3.7%) 0.94 0.27–2.95 1
L0 6 (1.1%) 1 (0.9%) 0.86 0.14–5.44 1
L1 3 (0.5%) 2 (1.9%) 3.49 0.40–25.9 0.19
L2 20 (3.6%) 6 (5.6%) 1.58 0.555–4.29 0.41
L3 22 (4%) 5 (4.7%) 1.18 0.38–3.39 0.79
L4 1 (0.2%) 2 (1.9%) 10.5 0.74–294.9 0.07
L5 4 (0.7%) 2 (1.9%) 2.61 0.33–16.70 0.25
M 17 (3.1%) 0 0.15 0.009–2.46 0.09
M1 19 (3.5%) 6 (5.6%) 1.67 0.58–4.56 0.27
N 41 (7.4%) 1 (0.9%) 0.12 0.01–0.81 0.02
preHV1 99 (17.9%) 31 (29%) 1.87 1.13–3.06 0.0127
R 17 (3.1%) 0 0.15 0.009–2.46 0.09
T 34 (6.2%) 4 (3.7%) 0.59 0.17–1.80 0.45
U 58 (10.5%) 10 (9.4%) 0.88 0.41–1.85 0.85
W 6 (1.1%) 0 0.425 0.024–7.67 0.59
X 15 (2.7%) 3 (2.8%) 1.03 0.23–3.88 1.0
Since we have 19 mitochondrial haplogroups, the Bonferroni correction should be 0.05/19=0.0026. Thus, a p-value<0.0026 was
considered significant.
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occurrence of glaucoma.
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